AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
The offer by Mumbai-based Cipla Ltd to supply a combination of three AIDS drugs at $350/y/patient to the poor patients in developing countries has pushed the company into limelight.
This move of Cipla has forced the industry majors like GlaxoSmithKline, Bristol-Myers Squibb and Merck & Co to follow suit.
A group of 39 companies decided to withdraw their court case filed in South Africa to prevent South Africa from importing cheap generic versions of their AIDS drugs.
This has cleared the way for Cipla to export the AIDS drugs to …